These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16532973)

  • 1. The role of inhaled long-acting beta-2 agonists in the management of asthma.
    Kelly HW; Harkins MS; Boushey H
    J Natl Med Assoc; 2006 Jan; 98(1):8-16. PubMed ID: 16532973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long acting beta-2 agonists in the treatment of asthma and their safety].
    Türktaş H; Sekerel B; Karakay G; Yildiz F; Yorgancioğlu A
    Tuberk Toraks; 2011; 59(4):409-15. PubMed ID: 22233316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with a long-acting beta2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma.
    Lee DK; Currie GP; Lipworth BJ
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):410-1; author reply 411-2. PubMed ID: 15801257
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological management of asthma.
    McDonald C; Lipp J
    Aust Fam Physician; 1998; 27(1-2):64-8, 70. PubMed ID: 9503709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial beta 2-agonists and their impartial assessment.
    Dickey BF; Clark RC; Barber R
    Chest; 1996 Nov; 110(5):1131-2. PubMed ID: 8915203
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
    Kim D; Glaum M; Lockey R
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of peak inspiratory flow with asthma: effect of inhaled beta2-stimulant].
    Shimizu K; Yamazaki Y; Kishimoto N; Tada S; Ueda N; Fujita J; Kamei T; Okada H; Arakawa Y; Nakamura H
    Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):216-20. PubMed ID: 15966367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events.
    Salpeter SR; Wall AJ; Buckley NS
    Am J Med; 2010 Apr; 123(4):322-8.e2. PubMed ID: 20176343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma therapy with aerosols: clinical relevance for the next decade.
    Barnes PJ
    J Aerosol Med; 1996; 9(1):131-41. PubMed ID: 10160203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
    Currie GP; Lee DK; Menzies D; Lipworth BJ
    Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal use of inhaled corticosteroids in children with persistent asthma: inadequate prescription, poor drug adherence, or both?
    Pando S; Lemière C; Beauchesne MF; Perreault S; Forget A; Blais L
    Pharmacotherapy; 2010 Nov; 30(11):1109-16. PubMed ID: 20973684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic interventions to reduce the risk of asthma exacerbations.
    O'Byrne PM
    Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application for Authorization for Therapeutic Use of Beta-Adrenergic Agonists and Inhaled Corticosteroids in Athletes with Asthma.
    Drobnic F; Blanco-Alfaro J
    Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):223-225. PubMed ID: 29102337
    [No Abstract]   [Full Text] [Related]  

  • 20. An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.
    Salpeter SR
    Expert Opin Drug Saf; 2010 May; 9(3):407-19. PubMed ID: 20408768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.